Latest Asx News

Native Mineral Resources has poured its first gold at the Blackjack Gold Project in Queensland, marking a pivotal shift from development to production with initial revenue generated.

Strategic Elements Ltd has marked significant progress in its Energy Ink™ prototype trials and underground mining technology, maintaining a robust financial footing with $4.21 million cash and no debt.

XPON Technologies reported a strong Q4 FY25 with a 27% revenue jump driven by its Alpha Digital acquisition, while targeting positive EBITDA and cash flow from Q2 FY26.

Everest Metals Corporation has revealed a promising 1.1km gold anomaly at its Revere project, completed a key rubidium extraction study at Mt Edon, and is poised to start mining at Mt Dimer by year-end.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

Everest Metals Corporation Ltd reported a cautious cash flow update for Q2 2025, highlighting ongoing exploration costs and a funding runway of just under two quarters. The company has completed bulk sampling at its Revere Gold Project but faces continued negative operating cash flows.

NT Minerals has advanced key asset sales including the Mountain Home and Redbank/Wollogorang projects, while facing a critical cash position and awaiting shareholder approval for its latest disposal deal.

Red Hill Minerals reported robust royalty revenues and exploration progress in the June 2025 quarter, underpinned by strong iron ore shipments and strategic royalty acquisitions. The company’s solid cash position and advancing drill programs position it well for growth.

NEXION Group Ltd has exited a major transaction, sold its Perth data centre, and relaunched its AI-focused subsidiary, positioning itself for renewed growth and ASX reinstatement.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir ahead of schedule, setting sights on expedited FDA approval leveraging the Animal Rule.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project for A$6 million cash plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project. The transaction strengthens Juno’s cash position and sets the stage for renewed development efforts.

Battery Age Minerals has initiated its maiden drilling campaign at the Bleiberg Zinc-Germanium Project following regulatory approval, while advancing exploration at El Aguila with a $3 million capital raise backing its growth.